Tag Archives: regulatory affairs
US Mid-Term Elections: What It Means for Pharma
Daily News Nugget
US Mid-Term Elections: What it Means for Pharma
Drink up, even if it’s only old wine in new bottles…
Yesterday’s mid-term congressional poll barely changes the stakes for pharma in its pursuit of its US legislative and regulatory agenda. The key message coming out of the results is stalemate on the big issues like [...]
Posted in Op-Ed, Regulatory Also tagged Congress, Democrats, healthcare reform, legislation, mid-term elections, Republicans, Senate 2 Comments
And What Exactly is a Stakeholder?
Pharma’s uncritical use of the word ‘stakeholder’ has increased to the point where it can refer to almost anyone connected to the industry. But this can have serious consequences, warns Reflector.
Like it or not (and frankly, I don’t), stakeholders are here to stay in European pharmaceutical affairs. Don’t get me wrong. I’ve no objection to [...]
Posted in Europe, Global, Guest Blog, Regulatory Also tagged EC, EHPA, EU, Europe, European Community, European Union, stakeholder, TOPRA 1 Comment

Regulator Move Re-Opens Arguments over European Transparency